The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Photodynamic Therapy Using Topical Methyl Aminolevulinate vs Surgeryfor Nodular Basal Cell Carcinoma: Results of a Multicenter Randomized Prospective Trial
Abstract
BACKGROUND: Photodynamic therapy (PDT) is increasingly used as a noninvasive treatment for nodular basal cell carcinoma (BCC), without a sound evidence base. OBJECTIVE: To compare topical PDT, with the use of the sensitizer methyl aminolevulinate, and standard excision surgery in nodular BCC. DESIGN: Prospective, randomized study. SETTING: University dermatology departments. PATIENTS: A total of 101 adults with previously untreated nodular BCC. INTERVENTIONS: Patients received methyl aminolevulinate PDT (n = 52) or surgery (n = 49). The PDT was given twice, 7 days apart, with methyl aminolevulinate cream (160 mg/g) and 75 J/cm(2) red light (570-670 nm). Thirteen patients with a noncomplete response to PDT at 3 months (24% lesions) were retreated. OUTCOME MEASURES: Primary end point was clinically assessed lesion clearance at 3 months after treatment. Secondary end points were sustained response rate at 12 months and cosmetic outcome at 3 and 12 months. Cosmesis and lesion recurrence were further assessed at 24 months. RESULTS: Data from 97 patients (105 lesions) were included in the 3-month per-protocol analysis. Complete response rates did not differ significantly between groups (51/52 [98%] lesions with surgery vs 48/53 [91%] lesions with methyl aminolevulinate PDT; difference [95% confidence interval], 4.8% (-3.4% to 13.0%]; P =.25). At 12 months, tumor-free rates were 50 (96%) of 52 lesions with surgery vs 44 (83%) of 53 with methyl aminolevulinate PDT (P =.15). More patients treated with methyl aminolevulinate PDT than surgery had an excellent or good cosmetic outcome at all time points (significant at 12 and 24 months on patient assessment, P<.05, and at 3, 12, and 24 months on investigator evaluation, P<.001). At 24 months, 5 lesions that had initially cleared with methyl aminolevulinate PDT had recurred, compared with 1 after surgery. CONCLUSIONS: Methyl aminolevulinate PDT is an effective treatment for nodular BCC, and while there is a trend for higher recurrence with this modality, it conveys the advantage over surgery of better cosmesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for the management of basal cell carcinoma
Telfer, N. R., Colver, G. B., & Morton, C. A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08666.x · Cited by 960
ROWE, D. E., CARROLL, R. J., & JR. DAY, C. L. (1989) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1989.tb03166.x · Cited by 802
Morton, C. A., Brown, S. B., Collins, S., Ibbotson, S., Jenkinson, H., Kurwa, H., Langmack, K., Mckenna, K., Moseley, H., Pearse, A. D., et al. (2002) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2002.04719.x · Cited by 451
Self-citationA Systematic Review of Treatment Modalities for Primary Basal Cell Carcinomas
Thissen, M. R. T. M., Neumann, M. H. A., & Schouten, L. J. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.10.1177 · Cited by 388
Guidelines for the management of basal cell carcinoma
Telfer, Colver, & Bowers (1999) · British Journal of Dermatology · doi:10.1046/j.1365-2133.1999.03033.x · Cited by 339
Photodynamic therapy vs. cryosurgery of basal cell carcinomas: results of a phase III clinical trial
Wang, I., Bendsoe, N., Klinteberg, C. A., Enejder, A. M. K., Andersson-Engels, S., Svanberg, S., & Svanberg, K. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04141.x · Cited by 309
Estimates of ozone depletion and skin cancer incidence to examine the Vienna Convention achievements
Slaper, H., Velders, G. J. M., Daniel, J. S., de Gruijl, F. R., & van der Leun, J. C. (1996) · Nature · doi:10.1038/384256a0 · Cited by 297
Recurrence Rates of Treated Basal Cell Carcinomas: Part 3: Surgical Excision
SILVERMAN, M. K., KOPF, A. W., BART, R. S., GRIN, C. M., & LEVENSTEIN, M. S. (1992) · The Journal of Dermatologic Surgery and Oncology · doi:10.1111/j.1524-4725.1992.tb03307.x · Cited by 251
Nambour Study Group, Green, A., Battistutta, D., Hart, V., Leslie, D., & Weedon, D. (1996) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a008875 · Cited by 242
Soler, A. M., Warloe, T., Berner, A., & Giercksky, K. E. (2001) · British Journal of Dermatology · doi:10.1046/j.1365-2133.2001.04407.x · Cited by 219
Cited by
Photodynamic therapy of cancer: An update
Agostinis, P., Berg, K., Cengel, K. A., Foster, T. H., Girotti, A. W., Gollnick, S. O., Hahn, S. M., Hamblin, M. R., Juzeniene, A., Kessel, D., et al. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20114 · Cited by 5,145
Clinical development and potential of photothermal and photodynamic therapies for cancer
Li, X., Lovell, J. F., Yoon, J., & Chen, X. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0410-2 · Cited by 3,456
The present and future role of photodynamic therapy in cancer treatment
Brown, S. B., Brown, E. A., & Walker, I. (2004) · The Lancet Oncology · doi:10.1016/s1470-2045(04)01529-3 · Cited by 1,771
In vivo photodynamic therapy using upconversion nanoparticles as remote-controlled nanotransducers
Idris, N. M., Gnanasammandhan, M. K., Zhang, J., Ho, P. C., Mahendran, R., & Zhang, Y. (2012) · Nature Medicine · doi:10.1038/nm.2933 · Cited by 1,464
Nanoparticles in photodynamic therapy: An emerging paradigm
Chatterjee, D. K., Fong, L. S., & Zhang, Y. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.08.003 · Cited by 1,184
Guidelines for the management of basal cell carcinoma
Telfer, N. R., Colver, G. B., & Morton, C. A. (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08666.x · Cited by 960
Rubin, A. I., Chen, E. H., & Ratner, D. (2005) · New England Journal of Medicine · doi:10.1056/nejmra044151 · Cited by 769
Photodynamic Therapy in Oncology
Triesscheijn, M., Baas, P., Schellens, J. H. M., & Stewart, F. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-9-1034 · Cited by 737
Braathen, L. R., Szeimies, R.-M., Basset-Seguin, N., Bissonnette, R., Foley, P., Pariser, D., Roelandts, R., Wennberg, A.-M., & Morton, C. A. (2007) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2006.06.006 · Cited by 662
Mesoporous‐Silica‐Coated Up‐Conversion Fluorescent Nanoparticles for Photodynamic Therapy
Qian, H. S., Guo, H. C., Ho, P. C., Mahendran, R., & Zhang, Y. (2009) · Small · doi:10.1002/smll.200900692 · Cited by 619
Beyond the margins: real-time detection of cancer using targeted fluorophores
Zhang, R. R., Schroeder, A. B., Grudzinski, J. J., Rosenthal, E. L., Warram, J. M., Pinchuk, A. N., Eliceiri, K. W., Kuo, J. S., & Weichert, J. P. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.212 · Cited by 485
Guidelines for topical photodynamic therapy: update
Morton, C. A., McKenna, K. E., Rhodes, L. E., & on behalf of the British Association of Dermatologists Therapy Guidelines and Audit Subcommittee and the British Photodermatology Group (2008) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2008.08882.x · Cited by 471
Self-citationInterventions for basal cell carcinoma of the skin
Bath-Hextall, F. J., Perkins, W., Bong, J., & Williams, H. C. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003412.pub2 · Cited by 357
Morton, C. A., Szeimies, R. ‐., Sidoroff, A., & Braathen, L. R. (2013) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.12031 · Cited by 344
Hasan, N., Nadaf, A., Imran, M., Jiba, U., Sheikh, A., Almalki, W. H., Almujri, S. S., Mohammed, Y. H., Kesharwani, P., & Ahmad, F. J. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01854-3 · Cited by 322
Upconverting Nanoparticles as Nanotransducers for Photodynamic Therapy in Cancer Cells
Chatterjee, D. K., & Yong, Z. (2008) · Nanomedicine · doi:10.2217/17435889.3.1.73 · Cited by 298
Management of nonmelanoma skin cancer in 2007
Neville, J. A., Welch, E., & Leffell, D. J. (2007) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0883 · Cited by 278
Rhodes, L. E., de Rie, M. A., Leifsdottir, R., Yu, R. C., Bachmann, I., Goulden, V., Wong, G. A. E., Richard, M.-A., Anstey, A., & Wolf, P. (2007) · Archives of Dermatology · doi:10.1001/archderm.143.9.1131 · Cited by 275
“of lesions 0 0 1 2 2 Proportion (95% CI) of lesions, % 0 (0-100) 0 (0-100) 2 (0-10) 4 (1-13) 4 (1-13)c Lesion size, mmd 10 0 0 0 0 0 10 and 20 0 0 1 2 2”
Self-citationMorton, C., Horn, M., Leman, J., Tack, B., Bedane, C., Tjioe, M., Ibbotson, S., Khemis, A., & Wolf, P. (2006) · Archives of Dermatology · doi:10.1001/archderm.142.6.729 · Cited by 256
Self-citationCurrent evidence and applications of photodynamic therapy in dermatology
Lin, J., & Wan, M. T. (2014) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s35334 · Cited by 248
5‐Aminolevulinic Acid Derivatives in Photomedicine: Characteristics, Application and Perspectives
Fotinos, N., Campo, M. A., Popowycz, F., Gurny, R., & Lange, N. (2006) · Photochemistry and Photobiology · doi:10.1562/2006-02-03-ir-794 · Cited by 238
“In contrast to the previously cited studies, all of which are noncomparative, a European study (130) directly compared MAL”
ResultVinciullo, C., Elliott, T., Francis, D., Gebauer, K., Spelman, L., Nguyen, R., Weightman, W., Sheridan, A., Reid, C., Czarnecki, D., et al. (2005) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2005.06484.x · Cited by 158
Photodynamic Therapy for Non-Melanoma Skin Cancers
Cohen, D., & Lee, P. (2016) · Cancers · doi:10.3390/cancers8100090 · Cited by 128
Angell-Petersen, E., Sørensen, R., Warloe, T., Soler, A. M., Moan, J., Peng, Q., & Giercksky, K.-E. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700048 · Cited by 123
Guidelines for practical use of MAL‐PDT in non‐melanoma skin cancer
Christensen, E., Warloe, T., Kroon, S., Funk, J., Helsing, P., Soler, A., Stang, H., Vatne, Ø., & Mørk, C. (2010) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2009.03430.x · Cited by 120
de Haas, E. R. M., Kruijt, B., Sterenborg, H. J. C. M., Martino Neumann, H. A., & Robinson, D. J. (2006) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5700460 · Cited by 118
“Rhodes et al. (2004) performed a comparative study using MAL-PDT versus surgery for nodular basal cell carcinomas, achieving 10% recurrence rate in the MAL-PDT group versus 2% recurrence rate in the surgery group.”
Foley, P., Freeman, M., Menter, A., Siller, G., El‐Azhary, R. A., Gebauer, K., Lowe, N. J., Jarratt, M. T., Murrell, D. F., Rich, P., et al. (2009) · International Journal of Dermatology · doi:10.1111/j.1365-4632.2008.04022.x · Cited by 92
Photodynamic Therapy and Non-Melanoma Skin Cancer
Griffin, L., & Lear, J. (2016) · Cancers · doi:10.3390/cancers8100098 · Cited by 81
“observed comparable responses for primary nodular BCC treated with MAL-PDT or surgical excision at 3 months (91% and 98% respectively), with greater recurrence rates but improved cosmesis in the PDT group [9].”
BackgroundSkiveren, J., Hædersdal, M., Philipsen, P., Wiegell, Sr., & Wulf, H. (2006) · Acta Dermato Venereologica · doi:10.2340/00015555-0128 · Cited by 72
Ricotti, C., Bouzari, N., Agadi, A., & Cockerell, C. J. (2009) · Medical Clinics of North America · doi:10.1016/j.mcna.2009.08.011 · Cited by 63
Christensen, E., Skogvoll, E., Viset, T., Warloe, T., & Sundstrøm, S. (2009) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/j.1468-3083.2008.02946.x · Cited by 54
Pye, A., & Curnow, A. (2007) · Photochemistry and Photobiology · doi:10.1562/2006-05-30-ra-906 · Cited by 45
Pye, A., Campbell, S., & Curnow, A. (2008) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-008-0358-6 · Cited by 32
Topical Methyl Aminolevulinate
Siddiqui, M. A. A., Perry, C. M., & Scott, L. J. (2004) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200405020-00006 · Cited by 24
Metadata
- Authors
- Rhodes, L. E., de Rie, M., Enström, Y., Groves, R., Morken, T., Goulden, V., Wong, G. A. E., Grob, J.-J., Varma, S., & Wolf, P.
- Venue
- Archives of Dermatology
- Publisher
- American Medical Association (AMA)
- Published
- 2004-01-01
- Volume
- 140
- Issue
- 1
- Pages
- 17-23
- ISSN
- 0003-987X (ISSN-L)
- OpenAlex
- W2130465532
- Cited by
- 355
- References
- 24
- FWCI
- 20.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.